Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Spectrum Pharmaceuticals

12/05/2022 22:01

* Spectrum Pharmaceuticals Inc  SPPI.OQ  reported a
quarterly
adjusted loss of 8 cents​​ per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 19 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Spectrum Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 9 cents​.
    * The mean earnings estimate of analysts had fallen by
about 9.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Spectrum Pharmaceuticals Inc shares had fallen by 43.2%
this
quarter and lost 42.3% so far this year.
    * The company reported a quarterly loss of $15.44 million.
    * Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 09:00 p.m.  ​All
figures in US dollars unless otherwise stated